Cardinal Health 303 Inc DBA Alaris Products Texium Closed Male Luer (CML), Model Number 10012241, Cardinal Health, SanDiego, CA. Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Texium Closed Male Luer (CML), Model Number 10012241, Cardinal Health, SanDiego, CA.
Brand
Cardinal Health 303 Inc DBA Alaris Products
Lot Codes / Batch Numbers
Model Number 10012241 (all lot numbers)
Products Sold
Model Number 10012241 (all lot numbers)
Cardinal Health 303 Inc DBA Alaris Products is recalling Texium Closed Male Luer (CML), Model Number 10012241, Cardinal Health, SanDiego, CA. due to Leaks: there is a risk of leakage at the female end of the Texium closed male luer (CML) when attached to a spin luer. (NOTE: users who connect the fe. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Leaks: there is a risk of leakage at the female end of the Texium closed male luer (CML) when attached to a spin luer. (NOTE: users who connect the female portion of the Texium closed male luer to fixed (one-piece) male luers on tubing or on syringes are not affected by this issue)
Recommended Action
Per FDA guidance
Recall notification was made via a Safety Alert Notification Letter dated August 30, 2007. Recall will be conducted through consignees (distributors) in the affected countries, as well as, direct customers for the Texium closed male luer. The customers and distributors will be notified by registered return receipt mail. For direct customers, separate letters will be sent to the Director of Nursing, Director of Materials and Director of Risk Management, and Director of Pharmacy at each facility. Distributors were sent multiple copies of the Safety Alert Notification and Tip Sheets; along with a cover letter outlining their responsibilities to complete the Safety Alert plan and notify their sub-account customers. The domestic letters (direct customers and distributors) were mailed on August 30, 2007 to all of the affected accounts. The international notifications will be coordinated out of the offices located in the affected countries. The appropriate international regulatory authorities will be notified of this issue, which will work with the country managers at each location.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
AR, CA, CO, HI, IL, IN, LA, ME, MD, MA, MI, MS, NH, NJ, NY, NC, OH, OR, PA, SC, TX, UT, VA, WA, WI
Page updated: Jan 10, 2026